“One of the most problematic data gaps for the Review has been trying to obtain robust data on the numbers of young people who go on to a hormone pathway at GIDS [NHS Gender Identity Service ...

Data obtained by the MoS reflects the massive rise in reported gender dysphoria, with 5,000 referrals to the NHS's Gender Identity Development Service for children (GIDS) in 2021/22 compared to ...

A clinical trial of puberty blockers for managing children and adolescents with gender incongruence, announced in February,1 still awaits regulatory and ethical approval, amid warnings by clinicians ...

Children will no longer be prescribed puberty blockers at gender identity clinics, NHS England has confirmed. The Government said it welcomed the “landmark decision”, adding it would help ...

From the Daily Mail story: The NHS‘s controversial child transgender ... to Tavistock’s Gender Identity Development Service (GIDS). In other words, children will not be pushed toward ...

However, some experts have warned that the NHS-commissioned study is “unethical ... also known as the Gender and Identity Development Service (GIDS). The 2024 Cass Review, launched after ...

Timely documentary telling the story of the rise and fall of the Tavistock Centre's Gender Identity Development Service (GIDS), now one of the NHS's most controversial units.

Few issues in contemporary medicine have generated as much controversy as the use of puberty blockers in gender distressed ...